Search Within

Sandra Pierina D'Angelo

Formats
  1. Meeting Abstract (137)
  2. Journal Article (107)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (256)
  2. Hematologic Malignancies, Division of (256)
  3. Sarcoma Service (256)
  4. Solid Tumor Oncology Division (256)
  5. GSK Faculty (104)
  6. Tow Center for Developmental Oncology (TCDO) (91)

More Groups

People
  1. William Tap (107)
  2. Mark Dickson (86)
  3. Mrinal Gounder (75)
  4. Mary Keohan (73)
  5. Ping Chi (61)
  6. Cristina Antonescu (55)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Journal for ImmunoTherapy of Cancer (24)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (104)
  2. Biomed Central Ltd (26)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reveal: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: Local innate immune activation and systemic adaptive immune expansion for treating solid tumors
    Meeting Abstract

    Diab, A.; Curti, B.; Bilen, M.; Brohl, A.; Domingo-Musibay, E.; Borazanci, E.; Fanton, C.; Haglund, C.; Vimal, M.; Muhsin, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: Correlations of response with transduced cell kinetics and biomarkers
    Meeting Abstract

    Gyurdieva, A.; Zajic, S.; Chang, Y. F.; Houseman, E. A.; Zhong, S.; Kim, J.; Turner, D.; Johnson, L.; Eleftheriadou, I.; Tress, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Final analysis of the phase 1 trial of NY-ESO-1-specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS)
    Meeting Abstract

    D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Pandya, N.; Hasan, A.; Chiou, V.; Tress, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy and immune-related adverse event associations in avelumab-treated patients
    Journal Article

    Kelly, K.; Manitz, J.; Patel, M. R.; D'Angelo, S. P.; Apolo, A. B.; Rajan, A.; Kasturi, V.; Speit, I.; Bajars, M.; Warth, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Journal Article

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Dickson, M.; Gounder, M.; Keohan, M. L.; Chi, P.; Kelly, C.; Movva, S.; Nacev, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour
    Journal Article

    Cassier, P. A.; Italiano, A.; Gomez-Roca, C.; Le Tourneau, C.; Toulmonde, M.; D'Angelo, S. P.; Weber, K.; Loirat, D.; Jacob, W.; Jegg, A. M.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts
    Meeting Abstract

    Chen, J. L.; Mahoney, M. R.; George, S.; Antonescu, C. R.; Liebner, D. A.; Van Tine, B. A.; Milhem, M. M.; Tap, W. D.; Streicher, H.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save